Results 201 to 210 of about 112,766 (266)

Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Genetic clusters related to Type 2 diabetes (T2D) have differential impact on cardiovascular diseases (CVDs), although the underlying mechanisms, such as proteomic perturbation, remain unexplored. We conducted a network Mendelian randomisation (MR) study to identify proteomic mediators linking T2D genetic clusters and CVDs.
Shuang Liao   +4 more
wiley   +1 more source

Understanding and addressing resistance to IMiDs immunomodulatory compounds in multiple myeloma

open access: yesThe FEBS Journal, EarlyView.
IMiDs are pivotal in the treatment of multiple myeloma. Mechanisms of resistance comprise cell intrinsic and extrinsic pathways, involving tumour microenvironment, immune cell dysfunction, CRBN‐dependent and independent genetic drivers and epigenetic changes.
Maria‐Cynthia Fuentes‐Lacouture   +3 more
wiley   +1 more source

Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world. [PDF]

open access: yesAm J Prev Cardiol
Murdock DJ   +6 more
europepmc   +1 more source

Apolipoprotein B-48 and late graft failure in kidney transplant recipients. [PDF]

open access: yesClin Kidney J
Szili-Torok T   +5 more
europepmc   +1 more source

Concordance-discordance between apolipoprotein B and lipid biomarkers in predicting 20-year atherosclerotic cardiovascular disease risk: The ATTICA study (2002-2022). [PDF]

open access: yesEur J Clin Invest
Giannakopoulou SP   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy